Simplified guideline for prescribing medical cannabinoids in primary care

GM Allan, J Ramji, D Perry, J Ton, NP Beahm… - Canadian Family …, 2018 - cfp.ca
simplified medical cannabinoid prescribing guideline provides practical recommendations
for the use of medical cannabinoids … use of medical cannabinoids for most medical conditions …

Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline

JW Busse, P Vankrunkelsven, L Zeng, AF Heen… - bmj, 2021 - bmj.com
medical cannabis or cannabinoids Strong All or nearly all informed people would likely want
the intervention to the left. Benefits would outweigh harms for almost everyone Weak Most …

Safety considerations in cannabinoid-based medicine

S Gottschling, O Ayonrinde, A Bhaskar… - … of general medicine, 2020 - Taylor & Francis
guidelines, recommendations, and reviews on cannabinoids do not differentiate data from
studies in recreational and medical … the safety profiles of cannabinoid-based medicines. …

[HTML][HTML] Medical cannabis use in palliative care: review of clinical effectiveness and guidelines–an update

E MacDonald, K Farrah - 2019 - europepmc.org
… Recommendations for prescribing medical cannabinoids were developed for four broad … of
cannabinoids for palliative pain were developed and are relevant to this report. The guideline

Medicinal cannabis guidance and resources for health professionals to inform clinical decision making

M Graham, E Renaud, CJ Lucas, J Schneider… - Clinical Therapeutics, 2023 - Elsevier
medical practitioners to undertake safe, evidence-based decision making about medicinal
cannabis is facilitating access to quality guidance and guidelines … or cannabinoids are effective…

Practical recommendations for the use of medical cannabis

MF Arboleda, E Prosk - Cannabinoids and Pain, 2021 - Springer
cannabinoid-based treatments. Consequently, there is a growing need to develop clinical
guidelines for cannabinoid … Importantly, product selection may be greatly simplified by focusing …

Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms

GM Allan, CR Finley, J Ton, D Perry, J Ramji… - Canadian Family …, 2018 - cfp.ca
medical cannabinoid prescribing guideline. We focused on the conditions for which medical
cannabinoids … the development of a simplified primary care medical cannabinoid prescribing …

PEER simplified chronic pain guideline: Management of chronic low back, osteoarthritic, and neuropathic pain in primary care

CS Korownyk, L Montgomery, J Young, S Moore… - Canadian Family …, 2022 - cfp.ca
… If opioid use disorder is suspected, please refer to the PEER simplified guideline on … simplified
guideline for prescribing medical cannabinoids in primary care 5 addressed cannabinoid

Should You Recommend Cannabinoids for This Patient With Painful Neuropathy? Grand Rounds Discussion From Beth Israel Deaconess Medical Center

GW Smetana, JM Tetrault, KP Hill… - … of Internal Medicine, 2021 - acpjournals.org
… The Canadian guidelines recommend against medical cannabinoids as first- or second-line
therapy, owing to limited benefit and substantial risk for harms. Overall, the number needed …

[HTML][HTML] Medical cannabis for the treatment of chronic pain: a review of clinical effectiveness and guidelines

S Banerjee, S McCormack - 2019 - ncbi.nlm.nih.gov
… The guideline by Allan et al. recommends against the use of medical cannabinoids for
headache and pain due to rheumatologic conditions (including fibromyalgia, osteoarthritis, …